DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) $ in Thousands	Jun. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	Jul. 31, 2023 participant	Jun. 30, 2023 participant patient
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit | $	$ 258,208	$ 222,798
Working capital | $	$ 251,500	$ 233,600
Number of patients enrolled in trail | patient				65
Number of patients enrolled in trial with one dose of study drug received | participant				62
Number of participants enrolled in trial with one dose of study drug received with primary and secondary objectives met | participant			62